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Available online 28 March 2016One of the important elements of operation of cytochrome bc1 (mitochondrial respiratory complex III) is a large
scale movement of the head domain of iron–sulfur protein (ISP-HD), which connects the quinol oxidation site
(Qo) located within the cytochrome b, with the outermost heme c1 of cytochrome c1. Several mitochondrial
disease-relatedmutations in cytochrome b are located at the cytochrome b-ISP-HD interface, thus theirmolecular
effects can be associated with altered motion of ISP-HD. Using purple bacterial model, we recently showed that
one of such mutations— G167P shifts the equilibrium position of ISP-HD towards positions remote from the Qo
site as compared to the native enzyme [Borek et al., J. Biol. Chem. 290 (2015) 23781-23792]. This resulted in the
enhanced propensity of the mutant to generate reactive oxygen species (ROS) which was explained on the basis
of themodel evoking “semireverse” electron transfer from heme bL to quinone. Here we examine another muta-
tion from that group—G332D (G290D in human), ﬁnding that it also shifts the equilibrium position of ISP-HD in
the same direction, however displays less of the enhancement in ROS production. We provide spectroscopic in-
dication that G332Dmight affect the electrostatics of interaction between cytochrome b and ISP-HD. This effect,
in light of the measured enzymatic activities and electron transfer rates, appears to be less severe than structural
distortion caused by proline inG167Pmutant. Comparative analysis of the effects of G332D andG167P conﬁrms a
general prediction that mutations located at the cytochrome b-ISP-HD interface inﬂuence the motion of ISP-HD
and indicates that “pushing” ISP-HD away from the Qo site is themost likely outcome of this inﬂuence. It can also
be predicted that an increase in ROS production associated with the “pushing” effect is quite sensitive to overall
severity of this change with more active mutants being generally more protected against elevated ROS.
This article is part of a Special Issue entitled ‘EBEC 2016: 19th European Bioenergetics Conference, Riva del Garda,
Italy, July 2–6, 2016’, edited by Prof. Paolo Bernardi.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
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Domain movement1. Introduction
Cytochrome bc1 (mitochondrial complex III), a part of electron trans-
port chain (ETC), is involved in building of protonmotive force which is
utilized to produce ATP [1]. This protein is a homodimer, in which eachn–sulfur protein; ISP-HD, head
ethoxy-5-methyl-6-decyl-1,4-
EPR, electron paramagnetic
pecies.
6: 19th European Bioenergetics
y Prof. Paolo Bernardi.
. This is an open access article undermonomer contains from 3 to 11 subunits, depending on species [2]. The
catalytic core of this protein consists of only 3 subunits: cytochrome b,
cytochrome c1 and iron–sulfur protein (ISP). Its function is related to
electron transfer from quinol to cytochrome c and the translocation of
protons across the membrane. Communication between these
two pools of electron carriers is important for energetic efﬁciency of
ETC [3].
In the catalytic Q cycle of cytochrome bc1 [4,5], a complete cycle of
reactions occurs in two chains of cofactors embedded in the catalytic
core. In the high-potential c-chain, quinol oxidation site (Qo site) is con-
nectedwith cytochrome c reduction site by two cofactors: Rieske cluster
and heme c1, embedded in ISP and cytochrome c1, respectively. Move-
ment of the head domain of iron–sulfur protein (ISP-HD) between a
site close to the Qo site (Qo position) and a site on the cytochrome c1 in-
terface (c1 position) allows transfer of electrons via this chain [6–11]. Inthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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tion site (Qi site) by heme bL and heme bH embedded in cytochrome b.
Completion of the Q cycle requires two quinol molecules to be oxidized
at the Qo site. After oxidation of ﬁrst molecule of quinol at the Qo site
one electron is transferred via high-potential c-chain and is used to re-
duce one molecule of cytochrome c. The second electron derived from
oxidation of ﬁrst molecule of quinol is transferred via low-potential b-
chain and is used to reduce quinone to semiquinone at the Qi site. Elec-
trons derived from oxidation of second quinol molecule are used to re-
duce one molecule of cytochrome c at the cytochrome c reduction site
and to reduce semiquinone to quinol at the Q i site. In addition, a
cross-dimer electron transfer at the level of two hemes bL is possible
[12,13].
Each monomer of the human cytochrome bc1 complex is composed
of 11 subunits [2]. Among all of them, only cytochrome b is encoded by
mitochondrial DNA, whereas all the other subunits are of nuclear origin.
Numerous cytochrome b mutations identiﬁed so far are related with
diseases such as exercise intolerance, miopathy, cardiomiopathy and
neuropathies [14–17]. These mutations mostly exhibit a deﬁciency in
the enzymatic activity and decreased amount of some of complex III
subunits. Somemutationsmay also cause an increase in superoxide rad-
ical production [18]. To study themolecular effects of humanmitochon-
drial disease-related cytochrome bmutations, bacterial [19,20] or yeast
[17,21] systems are used.
In the present study we have used the Rhodobacter capsulatus
bacterial model to examine the molecular effects of mitochondrial
mutation G290D, which was identiﬁed in patient suffering from pro-
gressive exercise intolerance [22]. Earlier study of mitochondria iso-
lated from this patient's muscle showed a deﬁciency in the
enzymatic activity of cytochrome bc1 and decreased amounts of
some subunits: cytochrome b and ISP among others, while amounts
of cytochrome c1 were normal [23–25]. Gly-290 position in cyto-
chrome b is highly conserved among the species. It is localised in
the transmembrane helix F in the proximity of the Qo catalytic site
but also in close contact with ISP-HD at the Qo position (Fig. 1).
The mutation in R. capsulatus equivalent to human G290D is
G332D. The change from glycine to aspartic acid introduces structur-
al change (bulkier side chain) and additional negative charge. It thus
might perturb the structure of the Qo site pocket and/or affect theFig. 1. Position of Gly-332 in the structure of R. capsulatus cytochrome bc1. Close-up view of
the crystal structure of cytochrome bc1 (PDB: 1ZRT [46]) showing part of cytochrome b
(green) and ISP (light blue). Light pink and light orange sticks indicate heme bL and [2Fe–
2S] cluster, respectively. Yellow sticks represent the stigmatellin molecule in the Qo
catalytic site. Positions Gly-332 and Gly-167 aremarked as red andblue sticks, respectively.interaction of ISP-HD with cytochrome b, which could inﬂuence the
overall motion of ISP-HD. Recently, we found that another mitochon-
drial disease-related mutation G167P, located as G332D at the
cytochrome b-ISP-HD interface, did affect the motion of ISP-HD
which, among other effects, led to increased levels of superoxide
production at the Qo site [19]. In light of these ﬁndings we consid-
ered here G332D as a good candidate for the comparative analysis
with G167P.
2. Materials and methods
2.1. Mutagenesis
R. capsulatus containing the substitution of glycine to aspartate in
position 332 of cytochrome b subunit were obtained as follows. Muta-
tion was introduced in the petB gene (coding for cytochrome b) using
the QuikChange site-directed mutagenesis system (Stratagene) and
the following PCR primers (the changed nucleotide in the underlined
triplet is in bold): G332D_F: 5′-GATGCGAAGTTCTTCGACGTGATCGCGA
TGTTCGGCGC-3′ and G332D_R: 5′-GCCGAACATCGCGATCACGTCGAAG
AACTTCGCATCGAC-3′. As a template DNA pPET1 plasmid containing
wild type (WT) petABC operon and a Strep-tag at the C-terminal end
of cytochrome b was used [26]. The BstXI-AsuII fragment of the operon
bearing the desired mutations was inserted into the pMTS1 vector and
introduced into MT-RBC1 R. capsulatus strain using triparental crossing
[27]. The presence of introduced mutation was conﬁrmed by sequenc-
ing the whole petABC operon.
2.2. Bacterial growth
R. capsulatus cells were cultured in mineral-peptone-yeast-extract
(MPYE) at 30 °C either semiaerobically (at low oxygen concentration,
in dark) or photoheterotrophically (without oxygen, using BD GasPak
system, in the presence of light) as described previously [26]. The
growth rate estimations were performed as follows — a single colony
of analysed strain and of apparently similar size was cultured semi-
aerobically in 2 ml of MPYE supplemented with 10 μg/ml kanamycin
for ~14 h. 10 or 100 μl of such bacterial suspension was spread on
MPYE/Kan agar plates and the growth under photosynthetic conditions
was documented after 3, 5 and 7 days. 10 colonies of cells grown under
photosynthetic conditionswere re-streaked on new plates and their ge-
notypes were tested by DNA sequencing. All cells contained the G332D
mutation and no other mutations in the genes coding for all subunits of
the bc1 complex.
2.3. Isolation of chromatophores and protein puriﬁcation
Chromatophores were obtained from R. capsulatus cells grown
under semiaerobic conditions as described previously [28]. After iso-
lation, chromatophores were homogenized and suspended in MOPS
buffer pH 7.0 containing 100 mM KCl and 1 mM EDTA. Chromato-
phores were solubilized with n-dodecyl-β-D-maltopyranoside de-
tergent (DDM, Anatrace) for 45 min on ice (4 °C) and subsequently
ultracentrifuged. Supernatant was used for puriﬁcation of the
cytochrome bc1 complexes using the Strep-tag afﬁnity chromatogra-
phy following the manufacturer's protocol (IBA) with modiﬁcations
[26].
2.4. Steady-state kinetics and superoxide measurements
Enzymatic activities of isolated cytochrome bc1 complexes were de-
termined spectroscopically under steady-state conditions, at the begin-
ning of the 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzohydroquinone
(DBH2)-dependent reduction of cytochrome c (bovine heart cyto-
chrome c obtained from Sigma-Aldrich) as described previously [27].
All enzymatic assays were performed in 50 mM Tris buffer pH 8.0,
Table 1
Enzymatic activity of wild type, G332D and G167P cytochrome bc1 complexes.
Strain Enzymatic activity [1/s]a Flash-induced heme b reduction [1/s]
WTb 140 ± 5 818
G332D 45 ± 2 140
G167Pb 14.7 ± 0.2 16.6
a Errors represent standard deviation of the mean of 5–12 measurements.
b Data from [19].
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were calculated from the initial linear parts of the time-dependent cyto-
chrome c reduction kinetics. The kinetic parameters Vmax and KM were
calculated by ﬁtting Michaelis–Menten equation to data from Fig. 3.
The superoxide radical production was determined from the difference
between enzymatic activity with and without superoxide dismutase
(SOD) and was shown in Fig. 7A as percentage above the bars [29–31].
The concentration of CuZn-SOD was 100 U/ml. Cytochrome bc1 com-
plexes used in enzymatic assays were at ﬁnal concentration of 10–
100 nM. The ﬁnal concentrations of cytochrome c, quinone pool
(DBH2 + DB) and antimycin were 20 μM except for determination of
Vmax and KM values where DBH2 concentration was in the range of 0.5
to 20 μM.
2.5. Light-induced electron transfer measurements
Double beam time-resolved spectrophotometer was used tomea-
sure the kinetic properties of cytochrome bc1 heme cofactors. Tran-
sient kinetics of hemes b (560–570 nm) and hemes c (550–
540 nm) were obtained for chromatophores suspended in MOPS
buffer pH 7.0 containing 100 mM KCl and 1 mM EDTA. The measure-
ments were carried out under anaerobic conditions in the presence
of 3.5 μM valinomycin and redox mediators as described in [32,33].
Redox reactions were induced in chromatophores by single saturat-
ing light ﬂash (50 ms, wavelength above 580 nm) and measured
under conditions of pH 7.0 and 100 mV of ambient potential. The
rates of ﬂash-induced heme b reduction in the presence of antimycin
(Sigma-Aldrich) were calculated using a single exponential equation
ﬁtted to kinetic transients.
2.6. Electron paramagnetic resonance (EPR) measurements
Continuous wave EPR spectra of [2Fe–2S] cluster were measured at
X-band frequency (9.6 GHz) on chromatophores. Samples were pre-
pared in MOPS buffer pH 7.0 containing 100 mM KCl and 1 mM EDTA.
All spectra were measured at 20 K, using a SHQEOS11 resonator and
the following parameters: resonance frequency, 9.39 GHz; microwave
power, 1.545 mW; modulation amplitude, 15 G.
Pulsed EPR spectroscopy was used to obtain the temperature
dependence of phase relaxation rates of the reduced [2Fe–2S] cluster
as described previously [19,34]. Measurements were performed at
Q-band frequency (33.5 GHz) on isolated cytochrome bc1 complexes.
Samples were prepared in Bicine buffer pH 8.0 containing 100 mM
NaCl and 20% glycerol in the presence of reductant (1 mM sodium
ascorbate) and measured in the temperature range of 12–23 K. All
EPR measurements were carried on a Bruker Elexsys E580
spectrometer.
3. Results
3.1. G332D mutation affects the bc1-dependent growth of R. capsulatus
One of the ways to test the functionality of mutated cytochrome bc1
in bacteria is to observe its ability to sustain growth under the photo-
synthetic conditions. As the anoxygenic growth of R. capsulatus is de-
pendent on the functional electron transport chain, the lower growth
rate of bacteria bearing mutated cytochrome bc1 complex suggests im-
pediments in the complex operation. Upon introducing the G332D
mutation in the cytochrome b in R. capsulatus we observed that the
growth rate of mutated bacteria was dramatically slower than in
the wild type (Fig. 2A). When both strains were seeded in the same
amount, the growth of G332D could not be detected even after
7 days of culture. However, when the mutated bacteria were seeded
at 10-fold higher concentration, some growth was observed
(Fig. 2A). Under aerobic conditions, independent of functional bc1,the G332D bacteria exhibited growth rate comparable with the
wild type (data not shown).3.2. G332D mutant shows native-like subunit composition and optical
spectra of hemes
To testwhether theG332Dmutation affects the subunit composition
of the bc1 complexwe puriﬁed the complex using afﬁnity chromatogra-
phy. Visualization of the puriﬁedproteins on the SDS gel revealed that in
R. capsulatus themutated complex consists of all three catalytic subunits
— cytochrome b, cytochrome c1 and ISP (Fig. 2B). We have also investi-
gated the spectral properties of puriﬁed bc1 complexes bearing the
G332D mutation in comparison to the native enzyme. Thus we mea-
sured optical absorption spectra of these proteins under various oxida-
tive and reducing conditions (Fig. 2C). The spectra of oxidized hemes b
andhemes c, obtained in thepresence of 1mMsodium ferricyanide (red
traces) did not differ between G332D and WT. Addition of sodium
ascorbate reduced heme c in G332D (appearance of absorption peak
at 551 nm (Fig. 2C, black traces)) indicating that this heme is high po-
tential as in the native enzyme. Addition of potassium dithionite result-
ed in both WT and G332D in the additional maximum of absorption at
560 nm (Fig. 2C, green traces) corresponding to low-potential hemes
b. Moreover, the peak-to-peak ratio on dithionite-reduced spectra of
G332D (551 nm: 560 nm)did not reveal any signiﬁcant changes in com-
parison toWT indicating that the ratio of hemes c to b in themutant bc1
complex was not changed.3.3. G332D mutant exhibits lower enzymatic activity than wild type bc1
complex
Themeasurements of enzymatic activity at 20 μM cytochrome c and
20 μM quinol revealed that isolated bc1 complex bearing G332D muta-
tion is approximately 3-fold less active than the wild type (Table 1).
The same result of decrease enzymatic activitywas obtained bymeasur-
ing Vmax for different concentrations of quinol with 20 μMcytochrome c
(Fig. 3).When compared to theWT, G332Dmutant exhibited 3-fold de-
cline in Vmax (45 ± 2 s−1 and 146 ± 9 s−1 for G332D and WT, respec-
tively) and 2-fold decline in KM (1.1 ± 0.2 μM and 2.3 ± 0.5 μM for
G332D and WT, respectively).
Using ﬂash-induced double wavelength spectrophotometry we
were able to monitor the redox reactions of heme cofactors within
the bc1 complex in chrompatophores. Kinetic transients showed in
Fig. 4 represent oxidation and reduction of hemes as a result of
light-activated electron transfer through cofactor chains during the
Q cycle. Transients of hemes b (Fig. 4A) obtained for G332D chro-
matophores in the presence of antimycin (red traces) indicate
lower reduction rate in comparison to wild type (approximately 6-
fold, Table 1). Also the rates of cytochrome c re-reduction are signif-
icantly slower for G332D mutant compared to WT both for non-
inhibited (Fig. 4B, black traces) and antimycin-inhibited samples
(Fig. 4B, red traces).
Fig. 2.Photosynthetic growth, subunit composition and optical spectra of hemes inWTandG332Dmutant. A – comparison of photoheterotrophic growth ofwild typeR. capsulatus and the
G332D mutant after 3, 5 and 7 days of culture. To be able to observe the growth of the mutant cells they had to be seeded in about 10-fold higher concentration of bacteria than the wild
type. B – SDS-PAGE analysis of the afﬁnity-puriﬁed complexes;M – the proteinmassmarker in kDa. C – comparison of the optical spectra of hemes b and c of puriﬁedwild type andG332D
complexes. Samples were oxidized with ferricyanide (red traces) and reduced with sodium ascorbate (black traces) or dithionite (green traces).
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fects the equilibrium position of ISP-HD
Fig. 5 compares continuous wave electron paramagnetic resonance
(CW EPR) spectra of WT and G332D mutant. Clearly, the characteristic
resonance transition gx = 1.80, reﬂecting the interactions of the re-
duced Rieske cluster with quinone in the Qo site of the wild type com-
plex [35,36] was not observed in the G332D mutant (Fig. 5A). The
spectrum of non-inhibited G332D mutant exhibited a gx transition of
1.76, which is similar to a spectrum of WT after quinone extractionFig. 3. Comparison of enzymatic activities of WT and G332D mutant. The plots show
dependence of the turnover rate of WT (black) and G332D mutant (red) in the function
of quinol (DBH2) concentration. The Michaelis–Menten equation was ﬁtted to the data
points and yielded the Vmax and KM values.(empty Qo site) [37]. Moreover, addition of myxothiazol did not alter
the shape of G332D spectrum.
To investigate whether the presence of G332D inﬂuences the move-
ment of the ISP-HD, which could be one of the reasons for the observed
changes in the CW EPR spectra of [2Fe–2S] cluster in this mutant, we
measured the temperature-dependence of phase relaxation rates of
the cluster in wild type and in G332D cytochrome bc1. These measure-
ments monitor the distance-dependent interactions between the
[2Fe–2S] cluster and heme bL. The oxidized heme bL can enhance theFig. 4. Comparison of light-activated kinetics ofWT andG332Dmutant. A– kinetic transients
of hemes b reduction recorded at 560–570 nm, B – oxidation and re-reduction of hemes c
observed at 550–540 nm. All traces were recorded at pH 7 and ambient potential of 100
mV without inhibitors (black), in the presence of antimycin (red) and antimycin with
subsequent addition of myxothiazol (blue).
Fig. 5. Comparison of EPR spectra of [2Fe–2S] cluster inWT and G332Dmutant. A – X-band CWEPR spectra of [2Fe–2S] cluster of bc1 complex in chromatophores isolated fromwild type
and G332Dmutant. Traces were recorded in the absence of inhibitors (black traces) or in the presence of myxothiazol (blue traces). B – change in shape of the EPR spectrum of [2Fe–2S]
cluster in G332D in various salt concentrations.
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two paramagnetic centres are, the stronger the enhancement of phase
relaxation is. We have successfully used this approach to estimateFig. 6. Temperature dependence of phase relaxation rate of [2Fe–2S] cluster inWT andG332D cy
exponent to the electron spin echo decay measured by pulsed EPR at Q-band on isolated compl
B – G332D without inhibitors (green circles) and antimycin-inhibited (red circles). C – WT w
reduced with sodium ascorbate.changes in the average position of [2Fe–2S] cluster in relation to other
cofactors in the native enzyme and various mutants of R. capsulatus cy-
tochrome bc1 [19,31,34].tochrome bc1. Relaxation rates of the reduced [2Fe–2S] clusterwereobtained byﬁtting one
exes as a function of temperature; A –wild type (black circles) and G332D (green circles).
ithout inhibitors (black circles) and antimycin-inhibited (red circles). All samples were
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and G332D in Fig. 6A revealedweaker enhancement in themutant. This
indicates that the average equilibrium position of [2Fe–2S] cluster is
shifted in G332D towards a c1 position, more remote from heme bL. In
the presence of antimycin, G332D exhibited further decrease in relaxa-
tion rate (Fig. 6B) reminiscent of an even larger shift in the average po-
sition of the cluster away from the Qo site. Similar structural effect was
observed in the antimycin–inhibited wild type (Fig. 6C), as recognized
earlier by this method [34] and in the EPR studies on oriented chro-
matophore membranes [38].
As the additional charge on the surface of cytochrome b in G332D
mutant can possibly affect electrostatics of interaction between cyto-
chrome b and ISP-HD, wemeasured CWEPR spectra of ISP in chromato-
phores in buffers with different concentration of NaCl. Interestingly,
the increase of ionic strength resulted in the slight, but clearly distin-
guishable appearance of gx = 1.80 transition at the expense of gx =
1.76 transition (Fig. 5B). For the highest NaCl concentration (400 mM)
the contribution of cytochrome bc1 complexes exhibiting the gx =
1.80 transition (characteristic for native-like interaction of ISP-HD
with the Qo site) could be estimated for 2–4% of the whole population.
3.5. G332D mutation results in increased reactive oxygen species produc-
tion in the presence of antimycin
The increased distance between Rieske cluster and the Qo site is one
of the conditions promoting generation of superoxide by cytochrome
bc1 [19,30,31]. Moreover, ROS production is inﬂuenced by the redoxFig. 7. Comparison of enzymatic activities and ROS production. A – activities were measured a
DBH2 + DB ratio) in the absence (light grey bars) and presence of SOD (dark grey bars). Th
reduced Q pool. Superoxide radical production is shown as percentage above the bars. B – pro
Q pool expressed “relatively” (as percentage of superoxide generated per single turnover).
(blue). C – “quantitative” production of superoxide (expressed as a number of μmol of supero
B. Error bars in A, B and C represent standard deviation of the mean of at least 4 measurementstate of the quinone pool (the Q pool) exhibiting the characteristic
bell-shaped dependence [19,39,40]. In the absence of any inhibitors,
we could not detect any ROS in G332D mutant by the SOD-dependent
measurements of superoxide production under variety of redox condi-
tions: when the redox state of the Q pool becamemore oxidized (by de-
creasing the ratio of quinol to Q pool) the enzymatic activity of G332D
cytochrome bc1 decreased to the same levels, regardless of the SOD
presence (Fig. 7A). However, after addition of antimycin the superoxide
production was detected at level exceeding that typically observed in
WT under the same conditions ([19], see also Fig. 7B). We thus com-
pared the dependence of ROS generation in various redox states of the
Q pool in antimycin-inhibited G332D and antimycin-inhibited WT.
With increasing oxidation of the Q pool the amount of superoxide
generation described “relatively” as a percentage of superoxide generat-
ed per single turnover increased for WT and G332D mutant (Fig. 7B).
The difference in percentage of superoxide production betweenmutant
andWTwasmore pronouncedwith the Q pool totally reduced (fraction
of DBH2 = 1). Under this condition, G332D mutant revealed approxi-
mately 2-fold higher level of antimycin-dependent ROS generation
than the WT (30% vs 17%, Fig. 7B). In antimycin-inhibited WT, the de-
pendence of superoxide generation rate (described “quantitatively” as
a number of μmol of superoxide produced by 1 μmol of the enzyme
per second) was bell-shaped with the maximum ROS generation at a
quinol to Q pool ratio of approximately 0.75 (Fig. 7C, black), consistent
with previous observations [39,40]. However, the G332D mutant did
not show such bell-shaped dependence (Fig. 7C, red). This observation
prompted us to examine antimycin-inhibited G167P, the mutantt pH 8.0 and 100 mM NaCl under varying redox states of the Q pool (decreasing DBH2 to
e last two bars represent enzymatic activities of antimycin-inhibited G332D in a fully-
duction of superoxide in antimycin-inhibited enzymes under varying redox states of the
The total concentration of the Q pool was 20 μM. WT (black), G332D (red) and G167P
xide produced by 1 μmol of the enzyme per second) corresponding to the plot shown in
s.
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[19]. Antimycin-inhibited G167P lacked the bell-shaped dependence
(Fig. 7C, blue), similarly to antimycin-inhibited G332D.4. Discussion
4.1. Comparison of structural effects associated with ROS production in
G332D and G167P
Our results reveal that mutation G332D in cytochrome b of
R. capsulatus inﬂuences the interaction of ISP-HD with cytochrome b
rather than the afﬁnity of cytochrome bc1 for quinol (a low KM for
G332D mutant indicates a high afﬁnity of the enzyme for quinol
(Fig. 3)). Based on EPR analysis of the CW and pulse EPR spectra of
[2Fe–2S] cluster we concluded that this inﬂuence manifests itself in a
shift in the equilibriumposition of ISP-HD towards the positionmore re-
mote from the Qo site (in comparison to the native enzyme). This mac-
roscopic effect appears similar to the shift observed earlier in G167P,
another mutation located at the cytochrome b-ISP-HD interface. How-
ever, while in G167P this shift was associated with the ability of mutant
to generate superoxide even in the absence of antimycin [19], in G332D
generation of superoxide could only be observed in the presence of
this inhibitor. This marks the major difference between these two
mutants.
The increased propensity of cytochrome bc1 to generate superoxide in
G167P [19] (in native complex no superoxide production is typically de-
tected in the absence of antimycin) was explained on the basis of
“semireverse” electron transfer favouring reactive oxygen species produc-
tion [30,31]. According to thismechanism, the back electron transfer from
the reduced heme bL to quinone results in formation of semiquinone at
the Qo site, which has the best chance to react with oxygen when the
ISP-HD occupies positions remote from the Qo site at the time of
semiquinone formation. We thus predicted that mutations that shift the
equilibrium position of ISP-HD towards a position more remote from
the Qo site should increase the level of ROS production. Indeed, both
G167P andG332D appear to fall into this category ofmutants showing el-
evated levels of ROS in the presence of antimycin (in comparison to wild
type [19,30]). However, the effect of G332D on ROS production is clearly
more subtle comparing to G167P, because the former does not produce
superoxide without inhibitors (Fig. 7A). To explain such difference one
can propose that a shift in the average ISP-HD position is larger in
G167P than in G332D. We note that the sensitivity of the method based
on measurements of enhancement of [2Fe–2S] cluster relaxation de-
creases for larger distances between heme bL and the cluster. This
means that for the studied cases even if small changes in the average po-
sition between themutants G167P and G332D exist, theymay not neces-
sarily be resolved by this method. However, the assumption that the shift
in ISP-HD position may indeed be somewhat larger in G167P seems con-
sistent with the observation that G332D did not exert as severe impedi-
ments for enzymatic/electron transfer activity (Table 1, Fig. 4) and
photosynthetic growth (Fig. 2A) as G167P [19]. It is also reasonable
from the structural point of view: insertion of proline in G167P
may introduce more severe structural distortions than insertion of
aspartic acid in G332D which, as visualized by the results of Fig. 5B,
could predominantly affect the electrostatic interactions between
cytochrome b and ISP-HD. It is tempting to speculate that the shift
in G332D is at the borderline of structural change that just begins
to result in elevated ROS production (seen experimentally only in
the presence of antimycin) while the shift in G167P crosses that
line and elevated ROS become detectable even in the absence of
this inhibitor. It follows that within the group of enzymes shifting
the average position of ISP-HD away from the Qo site, even small dif-
ference in the shift (falling beyond the limits of detection by the de-
scribed above enhancement method) may result in signiﬁcant
difference in the ROS generation at the Qo site.4.2. Effect of the redox state of Q pool on ROS production by G332D and
G167P
Superoxide radical produced by cytochrome bc1 is a product of reac-
tion of semiquinone generated at theQo sitewith oxygen. There are two
possibleways, inwhich semiquinone can be created at this site: as a part
of forward reaction,when ﬁrst electron is transferred fromquinol to the
Rieskie cluster and the second electron transfer from semiquinone to
heme bL does not take place (“semiforward” reaction) [29,41] or as a
part of reverse reaction occurring when electron is transferred from
heme bL to quinone and the second electron transfer fromRieske cluster
to semiquinone does not take place (“semireverse” reaction) [30,31,39,
42]. Both of these mechanisms can, in principle, explain the production
of superoxide by the enzyme exposed to excess of quinol when oxida-
tion of hemes b is impeded in the presence of antimycin.
These two mechanisms differ in terms of the substrate used to gen-
erate oxygen-reactive semiquinone. In the “semiforward” mechanism,
the substrate is quinolwhile in the “semireverse”mechanism— it is qui-
none. This distinction guided the explanation of the previously observed
shape of dependence of ROS generation rate in antimycin-inhibited sub-
mitochondrial particles on the redox state of the Q pool [39]. Because
the maximum rate of superoxide generation was detected when the Q
pool was partly oxidized, the characteristic bell-shaped curve was as-
cribed as indicative of occurrence of “semireverse” reaction. Recent
studies revealed that suchbell-shaped dependence can also be observed
in the absence of antimycin. This concerned the mutant G167P, which
unlike WT and G332D, generates superoxide even in the absence of
this inhibitor [19].
Interestingly, such bell-shaped dependence was not observed in
antimycin-inhibited G332D mutant. Moreover, antimycin-inhibited
G167Pmutant did not show this dependence either (Fig. 7C). To explain
this observation one should consider that the presence of quinone at the
Qo site can have a dual effect on superoxide generation rate by cyto-
chrome bc1. On one hand, quinone as a competitive inhibitor of the
site decreases enzymatic activity of cytochrome bc1 (the major inﬂu-
ence on activity is when Q pool is nearly or fully oxidized) and thus
may reduce the rate of superoxide production calculated “quantitative-
ly”. On the other hand, according to “semireverse” electron transfer, qui-
none as a substrate for semiquinone generated at the Qo site increases
the level of superoxide radical production calculated “relatively”. The
competition between these two opposite effects impacts on the depen-
dence of superoxide production rate on the fraction of DBH2. The lack of
bell shape in both mutants in “quantitative” plot in the range between
0.5 and 1 (Fig. 7C) results from the lack of clear increment in levels of
ROS in “relative” plot in the range between 0.75 and 1 (Fig. 7B). In
WT, the increment concerns a change from 17% to nearly 40% of cyto-
chrome c reduction rate while in the mutants it starts from the level
as high as 30% and can further be increased only slightly, up to 43%
which is close to theoretical limit of ROS generation (50%). Thus “quan-
titative” ROS production inWT can reach amaximumwhen the fraction
of DBH2 is approximately 0.75 (this value is consistent with earlier ob-
servations reported for antimycin-inhibited submitochondrial particles
[39] and non-inhibited G167P mutant [19]). For the antimycin-
inhibited mutants, however, “quantitative” ROS production cannot in-
crease signiﬁcantly, as it would lead to levels of 50% or even more,
which would mean a total disruption of the Q cycle.
Based on these results we anticipate that not all mutants of cyto-
chrome bc1 will exhibit the characteristic bell-shaped dependence of
ROS production on the redox state of Q pool, but only those in which
the level of superoxide production in fully reduced state of quinone
pool is at moderate levels (not exceeding 30%).
4.3. Comparison of G332D in R. capsulatus with other species
Similarly to our results, G332D in another species of photosynthetic
purple bacteria, Rhodobacter sphaeroides also caused impediment in
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spectra of Rieske cluster in this mutant exhibit the gx transition of 1.77
[44], but no further studies on this mutation were reported for this spe-
cies. Mitochondrial complexes III from yeast and human bearing equiv-
alents of this mutation (G291D and G290D, respectively) were
enzymatically less active [21,23–25]. Additionally, the yeast G291Dmu-
tant was unable to grow on the complex III-dependent respiratory me-
dium. In both cases the authors ascribed these effects to the observed
lower amounts of cytochrome b and ISP. It thus appears that mitochon-
drial complex III with this mutation is generally less stable. While this
feature was not observed with bacterial cytochrome bc1, the decreased
stability of complex III may be associatedwith the change in ISP-HD po-
sition observed in bacteria. Indication that such correlation is possible
comes from the studies showing that the presence of antimycin
(which, as G332D, shifts the ISP-HD away from the Qo site) makes the
complex more prone to the proteolytic cleavage of ISP-HD [45], while
mutations and inhibitors acting in the opposite direction (i.e. ﬁxing
the ISP-HD at the Qo site) protect the complex from such cleavage [11,
45]. We note that yeast mutant S152P (equivalent of R. capsulatus
G167P mutation) showed almost complete lack of ISP subunit [21],
which again seems to correlate with the shift in the ISP-HD away from
the Qo site observed in bacteria [19]. Based on these observations one
can speculate that the correlation between molecular effect on the mo-
tion of ISP-HD (seen in G332D and G167P) and protein stability (seen in
G291D and S152P) extends to other mitochondrial mutations in cyto-
chrome b.
Interestingly, it was found that the respiratory dysfunction of G291D
mutant in yeast was partially restored by the additional mutation
D287H [21]. These twomutations are in the same region of cytochrome
b, only 3 Å apart. It thus would seem that a change from acidic amino
acid (aspartate) to positively charged histidine neutralizes the negative
charge introduced at the position 291 and such a compensatory effect
may be responsible for the partial restoration of the proper function of
the complex. This observation further supports the idea of the electro-
static nature of the ISP-HD shift caused by the G332D mutation.
4.4. Conclusions
If one considers G332D andG167P as two representatives of themu-
tations that target the cytochrome b-ISP-HD interface exerting various
structural distortions and/or changes in the surface charge (electrostatic
potential) it can be generalized that these types of mutations inﬂuence
themotion of ISP-HDwith a shift in the average position of ISP-HD away
from the Qo site being the most likely outcome of this inﬂuence. This
leads to an increase in ROS production consistent with the model evok-
ing “semireverse” electron transfer from heme bL to quinone as initial
reaction leading to formation of semiquinone that can react with oxy-
gen. The level of increase in ROS production and conditions under
which ROS are observed can vary depending on severity of the structur-
al change, with more activemutants (exhibiting larger enzymatic activ-
ity and electron transfer rates) being generally more protected against
elevated ROS. To observe the characteristic bell-shaped dependence of
ROS production on the redox state of the Q pool the tested form of cyto-
chrome bc1 should display moderate levels of ROS under fully reduced
state of the Q pool.
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